Embryo Transfer in Natural vs Substituted Cycle and the Scheduling Pattern of IVF
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Fertility Disorders
- Sponsor
- Clinique Ovo
- Enrollment
- 1207
- Locations
- 1
- Primary Endpoint
- Evaluate the clinical pregnancy rate of embryo transfer in natural vs substituted cycles
- Status
- Completed
- Last Updated
- 4 months ago
Overview
Brief Summary
In frozen embryo transfer substituted cycles, patients are treated with progesterone and estrogen in an attempt to mimic the natural cycle and a transfer is planned whenever the endometrium is ready. In contrast, in frozen embryo transfer natural cycle patients are not taking any hormones, only triggered with hCG (human chorionic gonadotropin) when a dominant follicle is ready or they wait for the disappearance of the dominant follicle to plan the transfer date. Some doctors and centres shift towards using the substituted protocol in an attempt to make scheduling easier with less frequent ultrasounds.
This study will aim to compare clinical and biochemical pregnancy rates in patients who underwent frozen embryo transfers in natural cycles vs substituted cycles at the centre.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age \< 40 years old
- •Women having undergone either a frozen embryo transfer in natural cycle or substituted cycle
- •IVF and FET cycles done at Clinique OVO
Exclusion Criteria
- •egg or embryo recipient
- •History of recurrent miscarriages, defined as ≥ 3 consecutive losses
- •Patients that needed Viagra, Plasma-Rich Platelet (PRP) or other modalities to improve their endometrial thickness
- •Uterine abnormalities
- •Abnormal hormonal profiles
- •FET Stimulated cycles
- •History of recurrent implantation failure defined as failed ≥ 2 euploid embryos transfer or ≥ 3 blastocysts
Outcomes
Primary Outcomes
Evaluate the clinical pregnancy rate of embryo transfer in natural vs substituted cycles
Time Frame: 6 to 8 weeks after Frozen Embryo Transfer
clinical pregnancy is the presence of fetal heartbeat at the viability ultrasound